Maria M. Perera

Las Palmas De Gran Canaria, CN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Allogeneic HCT as Consolidation in B-cell Lymphomas After Exposure to Bispecific Antibodies: A GETH-TC Study.

Allogeneic HCT as Consolidation in B-cell Lymphomas After Exposure to Bispecific Antibodies: A GETH-TC Study.

Journal: Blood advances

Published: August 20, 2025

Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study.

Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study.

Journal: Blood advances

Published: August 20, 2025

Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.

Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.

Journal: Bone marrow transplantation

Published: April 19, 2023

Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.

Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.

Journal: Bone marrow transplantation

Published: December 23, 2022

Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia.

Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia.

Journal: Scientific reports

Published: August 14, 2021

A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients.

A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients.

Journal: Blood cells, molecules & diseases

Published: August 31, 2020

Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia.

Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia.

Journal: Scientific reports

Published: August 29, 2019

Thrombopoietin receptor agonist switch in adult primary immune thrombocytopenia patients: A retrospective collaborative survey involving 4 Spanish centres.

Thrombopoietin receptor agonist switch in adult primary immune thrombocytopenia patients: A retrospective collaborative survey involving 4 Spanish centres.

Journal: European journal of haematology

Published: July 21, 2017

CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation.

CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation.

Journal: Bone marrow transplantation

Published: December 07, 2016

Advances in the pathophysiology of primary immune thrombocytopenia.

Advances in the pathophysiology of primary immune thrombocytopenia.

Journal: Hematology (Amsterdam, Netherlands)

Published: September 28, 2016

Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines.

Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines.

Journal: Annals of hematology

Published: December 29, 2015

Colony-stimulating factor-3 receptor, watch out for polymorphisms.

Colony-stimulating factor-3 receptor, watch out for polymorphisms.

Journal: Leukemia

Published: February 25, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026